Evidence map›Paper›PMID 38115038›Full record

ArticleFluids and barriers of the CNS2023

Methodological and analytical considerations for intra-operative microdialysis.

Cecile Riviere-Cazaux, Karishma Rajani, Masum Rahman, Juhee Oh, Desmond A Brown, Jaclyn F White, Benjamin T Himes, Ignacio Jusue-Torres, Moses Rodriguez, Arthur E Warrington and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04047264 (Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04047264 narecruitingnot on this map

Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

TypeinterventionalSponsorMayo ClinicRan2020 to 2027Enrolled100ConditionsGlioma, Glioblastoma, Metastatic Malignant Neoplasm in the BrainArmsMicrodialysis, Magnetic Resonance Imaging, Computed Tomography
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Cecile Riviere-CazauxDepartment of Neurological Surgery, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA.
Karishma RajaniDepartment of Neurological Surgery, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA.
Masum RahmanDepartment of Neurological Surgery, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA.
Juhee OhBrain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
Desmond A BrownNeurosurgical Oncology Unit, Surgical Neurology Branch, National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Jaclyn F WhiteDepartment of Neurological Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA.
Benjamin T HimesDepartment of Neurological Surgery, Montefiore/Albert Einstein College of Medicine, Bronx, NY, USA.
Ignacio Jusue-TorresDepartment of Neurological Surgery, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA.
Moses RodriguezDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Arthur E WarringtonBrain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
Sani H KizilbashDepartment of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
William F ElmquistBrain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
Terry C BurnsDepartment of Neurological Surgery, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA. Burns.Terry@mayo.edu.
Mayo Clinic · USMayo Clinic in Arizona · USUniversity of Minnesota · USAlbert Einstein College of Medicine · USAtrium Health Wake Forest Baptist · USNational Institutes of Health · USNeurological Surgery · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
MSTP at Mayo Clinic RochesterT32GM145408 · NIGMS · MAYO CLINIC ROCHESTER · PI SCOTT H KAUFMANN, LISA A SCHIMMENTI · 2023 to 2026
$4.7M
Glioma intelligence from behind enemy linesR37CA276851 · NCI · MAYO CLINIC ROCHESTER · PI Terry Burns · 2023 to 2026
$2.1M
Intracranial D-2-Hydroxyglutarate as a Monitoring Biomarker for IDH-mutant Glioma.R61NS122096 · NINDS · MAYO CLINIC ROCHESTER · PI BURNS, TERRY · 2022 to 2024
$1.2M
Intracranial D-2-Hydroxyglutarate as a Monitoring Biomarker for IDH-mutant Glioma.R33NS122096 · NINDS · MAYO CLINIC ROCHESTER · PI Terry Burns · 2025 to 2026
$756k
NCATS NIH HHS UL1 TR002377NCI NIH HHS CA276851NCI NIH HHS R37 CA276851NIGMS NIH HHS T32 GM145408NIH HHS T32GM145408NINDS NIH HHS NS122096NINDS NIH HHS R33 NS122096NINDS NIH HHS R61 NS122096
6 · The paper itself

Abstract

backgroundMicrodialysis is a technique that can be utilized to sample the interstitial fluid of the central nervous system (CNS), including in primary malignant brain tumors known as gliomas. Gliomas are mainly accessible at the time of surgery, but have rarely been analyzed via interstitial fluid collected via microdialysis. To that end, we obtained an investigational device exemption for high molecular weight catheters (HMW, 100 kDa) and a variable flow rate pump to perform microdialysis at flow rates amenable to an intra-operative setting. We herein report on the lessons and insights obtained during our intra-operative HMW microdialysis trial, both in regard to methodological and analytical considerations.

methodsIntra-operative HMW microdialysis was performed during 15 clinically indicated glioma resections in fourteen patients, across three radiographically diverse regions in each patient. Microdialysates were analyzed via targeted and untargeted metabolomics via ultra-performance liquid chromatography tandem mass spectrometry.

resultsUse of albumin and lactate-containing perfusates impacted subsets of metabolites evaluated via global metabolomics. Additionally, focal delivery of lactate via a lactate-containing perfusate, induced local metabolic changes, suggesting the potential for intra-operative pharmacodynamic studies via reverse microdialysis of candidate drugs. Multiple peri-operatively administered drugs, including levetiracetam, cefazolin, caffeine, mannitol and acetaminophen, could be detected from one microdialysate aliquot representing 10 min worth of intra-operative sampling. Moreover, clinical, radiographic, and methodological considerations for performing intra-operative microdialysis are discussed.

conclusionsIntra-operative HMW microdialysis can feasibly be utilized to sample the live human CNS microenvironment, including both metabolites and drugs, within one surgery. Certain variables, such as perfusate type, must be considered during and after analysis. Trial registration NCT04047264.

Indexed as

GliomaCathetersExtracellular FluidHumansLactic AcidMicrodialysisTumor MicroenvironmentLactic AcidGliomaIDHMass spectrometryMetabolomicsMicrodialysisPharmacokinetic

Identifiers

PMID38115038
PMCPMC10729367
OpenAlexW4389979616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.